Antitumor agents from agave schottii(amaryllidaceae)

E. Bianchi, J. R. Cole

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Extracts of Agave schottii Engelm. (Amaryllidaceae) were shown to be effective inhibitors of the Walker carcinoma 256 (intramuscular) tumor system of the CCNSC. The active material was shown to be saponin. By means of a Silica Gel G dry‐column technique, an effective separation of the acetates of the saponins present was accomplished. Gitogenin was identified as the genin of all saponins present. While the sugar associated with the saponin showing the highest degree of activity was galactose, the sugars associated with the three other saponins were identified as a mixture of galactose and glucose.

Original languageEnglish (US)
Pages (from-to)589-591
Number of pages3
JournalJournal of pharmaceutical sciences
Volume58
Issue number5
DOIs
StatePublished - May 1969

Keywords

  • Antitumor screening—Agave schottii saponins
  • Dry Column chromatography—separation
  • Saponins, extraction—Agave schottii
  • TLC—identity

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Antitumor agents from agave schottii(amaryllidaceae)'. Together they form a unique fingerprint.

Cite this